Pharmacist-led medication review for lung health in people with HIV
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a pharmacist-led medication check can improve lung health in people with HIV. It looks at three groups: people who smoke, people taking inhaled steroids for their lungs, or people taking acid-reducing medicines for heartburn. The goal is to see if optimizing medications can help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be living with HIV and taking antiretroviral therapy (ART) within the last 6 months
- Your HIV viral load must be under 200 copies per mL within the last year
- You must be a patient at a VA (Veterans Affairs) facility
- You must be a current smoker, or take an inhaled corticosteroid (like an inhaler for lung disease) for more than 3 months, or take a proton pump inhibitor (a stomach acid medicine) for more than 3 months
- You cannot be in hospice or palliative care, or be in another interventional research study
- Your main HIV or primary care doctor must be at a VA (if you also have a non-VA doctor, you cannot join unless that doctor is your main provider)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study works with pharmacists at six Ryan White HIV clinics to help people with HIV quit smoking or using tobacco. If you have HIV, are 21 or older, and have already met with a pharmacist about tobacco, you may be able to join.
This study tests a harm-reduction approach to help people with HIV smoke fewer cigarettes and quit if they want, using an online tobacco program and varenicline (a quit-smoking medicine). You may be placed in one of two different study groups to compare how well the approaches work.
This study tests a combination of counseling and medication to help people with HIV stop smoking and cut down on heavy drinking. It aims to improve overall health and quality of life.
This trial tests smoking-cessation interventions to help people living with HIV quit smoking or smoke less. You may be eligible if you smoke, are actively engaged in HIV treatment, and can follow the study for about a year.
This trial tests ways to deliver tobacco-quit treatment more effectively for people living with HIV. You may help researchers compare different quit-support approaches to see what works best.
This study looks at how a specific e-cigarette affects health in people who have HIV and smoke cigarettes regularly. You might be able to join if you meet smoking, HIV care, and safety requirements and are not planning to quit right away.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.